R&D Head Ehlers Bows Out As Confidence In Biogen's Pipeline Suffers From Setbacks

 
• By Mandy Jackson

EVP Michael Ehlers swaps public company scrutiny for early-stage, venture-funded opportunities at Apple Tree Partners and Limelight Bio, while CMO and longtime Biogen executive Alfred Sandrock reclaims R&D oversight role.

Executive-exit
Biogen's Ehlers submitted his resignation to work at VC firm Apple Tree. • Source: Shutterstock

More from Leadership

More from Scrip